Tikun Olam Cannbit Pharmaceuticals Ltd. Logo

Tikun Olam Cannbit Pharmaceuticals Ltd.

A vertically integrated pharma company developing research-backed, EU-GMP medical cannabis products.

TKUN | TA

Overview

Corporate Details

ISIN(s):
IL0010843675
LEI:
Country:
Israel
Address:
Ha'arbaa Street 21, 6473921 Tel Aviv-Yafo
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Tikun Olam Cannbit Pharmaceuticals Ltd. is a pioneering pharmaceutical company specializing in medical cannabis. The company operates a vertically integrated model, managing the entire value chain from genetics and cultivation to EU-GMP certified manufacturing and distribution. It focuses on developing stable, high-yielding proprietary strains with precise cannabinoid profiles to create standardized, accurately dosed products. A core differentiator is its commitment to research and development, substantiated by over 35 clinical studies and numerous scientific publications that validate the efficacy of cannabis for various medical conditions. The company also provides dedicated clinical nursing support to tens of thousands of patients, guiding their treatment and documenting outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-04-24 14:21
Regulatory News Service
Rights Offering and Identifying Details for New Security: TIKUN OLAM R5
Hebrew (modern) 182.1 KB
2022-08-17 17:30
Regulatory News Service
Opening of Trading On August 18 2022-TIKUN OL CN W3
Hebrew (modern) 107.6 KB
2022-07-26 15:47
Regulatory News Service
Rights Offering and Identifying Details for New Securities-Correction
Hebrew (modern) 185.9 KB
2022-07-26 15:04
Regulatory News Service
Rights Offering and Identifying Details for New Securities-TIKUN OL CAN R4, TIK…
Hebrew (modern) 314.1 KB
2021-05-30 18:08
Regulatory News Service
Tikun Olam-Cannbit – Rights Offering and Identifying Details for New Security
Hebrew (modern) 430.0 KB
2020-10-14 14:50
Regulatory News Service
Tikun Olam Canb – Rights Offering and Identifying Details for New Security
Hebrew (modern) 431.2 KB

Automate Your Workflow. Get a real-time feed of all Tikun Olam Cannbit Pharmaceuticals Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tikun Olam Cannbit Pharmaceuticals Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tikun Olam Cannbit Pharmaceuticals Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan 4523
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden ELN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden ERMA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP

Talk to a Data Expert

Have a question? We'll get back to you promptly.